Skip to main content
OpenTrials

Clinical trial condition

Diabetes

Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.

2,489 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Diabetes trial results

Completed

Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

NCT00598793

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Walnut Creek, California, United States
  • Novo Nordisk Investigational Site Melbourne, Florida, United States
View all 27 locations
View Trial Details
Completed

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT01487798

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Bolton, United Kingdom
  • Novo Nordisk Investigational Site Cardiff, United Kingdom
  • Novo Nordisk Investigational Site Derby, United Kingdom
  • Novo Nordisk Investigational Site Dundee, United Kingdom
View all 17 locations
View Trial Details
Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

NCT00619697

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Ebreichsdorf, Austria
  • Novo Nordisk Investigational Site Feldkirch, Austria
  • Novo Nordisk Investigational Site Graz, Austria
  • Novo Nordisk Investigational Site Horn, Austria
View all 54 locations
View Trial Details
Completed

Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes

NCT00184561

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Guangzhou, Guangdong, China
  • Novo Nordisk Investigational Site Wuhan, Hubei, China
View Trial Details

Related conditions